🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrew Tutt

Institute of Cancer Research

ORCID: 0000-0001-8715-2901

Also affiliated with Institute of Cancer Research, CRUK Lung Cancer Centre of Excellence

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group”.

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2
N/A
3.5DataRank · unranked
168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0156-0
N/A
0.801DataRank · unranked
208 citations

Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen +95 more

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

Nature Cell Biology(2022)10.1038/s41556-021-00807-6
N/A
0DataRank · unranked
163 citations

Shudong Li, Yilun Sun, Andrew J. Wicks, Gwendoline Hoslett, Daniel Weekes +14 more

The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00796-x
N/A
0DataRank · unranked
10 citations

Miki Yoneyama, Erik Wennerberg, Tom Lund, Andrew Tutt, Alan Melcher +3 more

Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes

npj Breast Cancer(2025)10.1038/s41523-025-00719-w
N/A
0DataRank · unranked
12 citations

Rohit Bhargava, Virginia F. Borges, Edi Brogi, Rita Canas‐Marques, Fátima Cardoso +23 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159
N/A
0DataRank · unranked
450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

87MO Assessing tumour fraction of CSF cfDNA improves diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis (BCLM)

Annals of Oncology(2020)10.1016/j.annonc.2020.08.208
N/A
0DataRank · unranked
0 citations

Marjan Iravani, Alicia Okines, Mark Harries, Andrew Tutt, Clare M. Isacke +1 more